KR20120110955A - A functional beverage composition comprising taurine, inositol, vitamin c, vitamin b complex, potassium iodide as main ingredients - Google Patents
A functional beverage composition comprising taurine, inositol, vitamin c, vitamin b complex, potassium iodide as main ingredients Download PDFInfo
- Publication number
- KR20120110955A KR20120110955A KR1020110029163A KR20110029163A KR20120110955A KR 20120110955 A KR20120110955 A KR 20120110955A KR 1020110029163 A KR1020110029163 A KR 1020110029163A KR 20110029163 A KR20110029163 A KR 20110029163A KR 20120110955 A KR20120110955 A KR 20120110955A
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- juice
- beverage composition
- functional beverage
- taurine
- Prior art date
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title claims abstract description 110
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 75
- 229960003080 taurine Drugs 0.000 title claims abstract description 55
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 229960000367 inositol Drugs 0.000 title claims abstract description 33
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title claims abstract description 33
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 239000011720 vitamin B Substances 0.000 title claims abstract description 25
- 235000019156 vitamin B Nutrition 0.000 title claims abstract description 24
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 title claims description 107
- 239000002075 main ingredient Substances 0.000 title claims description 4
- 229940046001 vitamin b complex Drugs 0.000 title abstract description 5
- 229960004839 potassium iodide Drugs 0.000 title description 7
- 229960005070 ascorbic acid Drugs 0.000 title 1
- 239000000796 flavoring agent Substances 0.000 claims abstract description 46
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 37
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 37
- 239000011718 vitamin C Substances 0.000 claims abstract description 37
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 37
- 150000003839 salts Chemical class 0.000 claims abstract description 25
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 18
- 150000007524 organic acids Chemical class 0.000 claims abstract description 14
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 13
- 239000003755 preservative agent Substances 0.000 claims abstract description 13
- 229910052751 metal Inorganic materials 0.000 claims abstract description 12
- 239000002184 metal Substances 0.000 claims abstract description 12
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- 230000002335 preservative effect Effects 0.000 claims abstract description 9
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 9
- 239000004034 viscosity adjusting agent Substances 0.000 claims abstract description 8
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 45
- 235000019634 flavors Nutrition 0.000 claims description 39
- 239000000284 extract Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 244000131522 Citrus pyriformis Species 0.000 claims description 17
- 235000005979 Citrus limon Nutrition 0.000 claims description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 15
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 15
- 239000005715 Fructose Substances 0.000 claims description 15
- 229930091371 Fructose Natural products 0.000 claims description 15
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 15
- 235000015197 apple juice Nutrition 0.000 claims description 15
- 229960002920 sorbitol Drugs 0.000 claims description 15
- 229940107702 grapefruit seed extract Drugs 0.000 claims description 14
- 239000008213 purified water Substances 0.000 claims description 14
- 239000012141 concentrate Substances 0.000 claims description 13
- 239000011734 sodium Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- -1 30 ~ 3000mg Chemical compound 0.000 claims description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 235000005985 organic acids Nutrition 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 235000004936 Bromus mango Nutrition 0.000 claims description 4
- 235000009467 Carica papaya Nutrition 0.000 claims description 4
- 240000006432 Carica papaya Species 0.000 claims description 4
- 240000007228 Mangifera indica Species 0.000 claims description 4
- 235000014826 Mangifera indica Nutrition 0.000 claims description 4
- 235000009184 Spondias indica Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- LPNBBFKOUUSUDB-UHFFFAOYSA-N p-toluic acid Chemical compound CC1=CC=C(C(O)=O)C=C1 LPNBBFKOUUSUDB-UHFFFAOYSA-N 0.000 claims description 4
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical class CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- ZQVKTHRQIXSMGY-UHFFFAOYSA-N 4-Ethylbenzoic acid Chemical compound CCC1=CC=C(C(O)=O)C=C1 ZQVKTHRQIXSMGY-UHFFFAOYSA-N 0.000 claims description 2
- ATZHGRNFEFVDDJ-UHFFFAOYSA-N 4-propylbenzoic acid Chemical compound CCCC1=CC=C(C(O)=O)C=C1 ATZHGRNFEFVDDJ-UHFFFAOYSA-N 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 235000011430 Malus pumila Nutrition 0.000 claims description 2
- 235000015103 Malus silvestris Nutrition 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 235000015201 grapefruit juice Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 235000015205 orange juice Nutrition 0.000 claims description 2
- 235000013944 peach juice Nutrition 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 235000013948 strawberry juice Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 229940013618 stevioside Drugs 0.000 claims 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 230000003078 antioxidant effect Effects 0.000 abstract description 19
- 230000003908 liver function Effects 0.000 abstract description 8
- 238000001784 detoxification Methods 0.000 abstract description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract description 4
- 239000011591 potassium Substances 0.000 abstract description 4
- 229910052700 potassium Inorganic materials 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000026045 iodination Effects 0.000 abstract 3
- 238000006192 iodination reaction Methods 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 28
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 24
- 239000007788 liquid Substances 0.000 description 24
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 22
- 239000011630 iodine Substances 0.000 description 22
- 229910052740 iodine Inorganic materials 0.000 description 22
- 239000003963 antioxidant agent Substances 0.000 description 19
- 235000006708 antioxidants Nutrition 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 18
- 239000000843 powder Substances 0.000 description 14
- 235000007119 Ananas comosus Nutrition 0.000 description 13
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 13
- 235000009754 Vitis X bourquina Nutrition 0.000 description 13
- 235000012333 Vitis X labruscana Nutrition 0.000 description 13
- 240000006365 Vitis vinifera Species 0.000 description 13
- 235000014787 Vitis vinifera Nutrition 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 235000005152 nicotinamide Nutrition 0.000 description 13
- 239000011570 nicotinamide Substances 0.000 description 13
- 235000020733 paullinia cupana extract Nutrition 0.000 description 13
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 13
- 239000004376 Sucralose Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 229940109850 royal jelly Drugs 0.000 description 12
- 239000000600 sorbitol Substances 0.000 description 12
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 12
- 235000019408 sucralose Nutrition 0.000 description 12
- 241000234671 Ananas Species 0.000 description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 11
- 235000015424 sodium Nutrition 0.000 description 11
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 10
- 229960003512 nicotinic acid Drugs 0.000 description 10
- 230000002285 radioactive effect Effects 0.000 description 10
- 229960002477 riboflavin Drugs 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 9
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 229960003966 nicotinamide Drugs 0.000 description 9
- 235000001968 nicotinic acid Nutrition 0.000 description 9
- 239000011664 nicotinic acid Substances 0.000 description 9
- 229950001574 riboflavin phosphate Drugs 0.000 description 9
- 230000035882 stress Effects 0.000 description 9
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 229930003471 Vitamin B2 Natural products 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000019164 vitamin B2 Nutrition 0.000 description 8
- 239000011716 vitamin B2 Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 229930003451 Vitamin B1 Natural products 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 229960003495 thiamine Drugs 0.000 description 7
- 235000010374 vitamin B1 Nutrition 0.000 description 7
- 239000011691 vitamin B1 Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
- 235000018417 cysteine Nutrition 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000005495 thyroid hormone Substances 0.000 description 6
- 229940036555 thyroid hormone Drugs 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 210000001685 thyroid gland Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000003613 bile acid Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000004641 brain development Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003344 environmental pollutant Substances 0.000 description 4
- 210000001508 eye Anatomy 0.000 description 4
- ZTVZLYBCZNMWCF-UHFFFAOYSA-N homocystine Chemical compound [O-]C(=O)C([NH3+])CCSSCCC([NH3+])C([O-])=O ZTVZLYBCZNMWCF-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 231100000719 pollutant Toxicity 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 229940034208 thyroxine Drugs 0.000 description 4
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 102100026278 Cysteine sulfinic acid decarboxylase Human genes 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 208000024770 Thyroid neoplasm Diseases 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 108010058198 sulfoalanine decarboxylase Proteins 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 201000002510 thyroid cancer Diseases 0.000 description 3
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000015295 Cysteine Dioxygenase Human genes 0.000 description 2
- 108010039724 Cysteine dioxygenase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 239000007961 artificial flavoring substance Substances 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000004992 fission Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000004153 glucose metabolism Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000006984 memory degeneration Effects 0.000 description 2
- 208000023060 memory loss Diseases 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FJWLWIRHZOHPIY-UHFFFAOYSA-N potassium;hydroiodide Chemical compound [K].I FJWLWIRHZOHPIY-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 210000000844 retinal pigment epithelial cell Anatomy 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 235000021476 total parenteral nutrition Nutrition 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- ADVPTQAUNPRNPO-REOHCLBHSA-N 3-sulfino-L-alanine Chemical compound OC(=O)[C@@H](N)C[S@@](O)=O ADVPTQAUNPRNPO-REOHCLBHSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000020018 Cystathionine gamma-Lyase Human genes 0.000 description 1
- 108010045283 Cystathionine gamma-lyase Proteins 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- ADVPTQAUNPRNPO-UHFFFAOYSA-N alpha-amino-beta-sulfino-propionic acid Natural products OC(=O)C(N)CS(O)=O ADVPTQAUNPRNPO-UHFFFAOYSA-N 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003986 cell retinal photoreceptor Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ILRYLPWNYFXEMH-UHFFFAOYSA-N cystathionine Chemical compound OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 1
- 108010071044 cysteine decarboxylase Proteins 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical compound [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 description 1
- 230000010220 ion permeability Effects 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- BQZGVMWPHXIKEQ-UHFFFAOYSA-L iron(ii) iodide Chemical compound [Fe+2].[I-].[I-] BQZGVMWPHXIKEQ-UHFFFAOYSA-L 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000003088 neuroexcitatory effect Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940045613 taurine 1000 mg Drugs 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000006016 thyroid dysfunction Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/042—Lactic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0644—Taurine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/24—Non-sugar sweeteners
- A23V2250/262—Stevioside
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5054—Gellan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/506—Guar
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5108—Cellulose
- A23V2250/51082—Carboxymethyl cellulose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/606—Fructose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/616—Maltose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/641—Inositol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/642—Sorbitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/6422—Xylitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7042—Vitamin B1
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7044—Vitamin B2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
본 발명은 타우린, 이노시톨, 비타민C, 비타민 B군 및 요오드화칼륨을 주성분으로 함유하는 기능성 음료조성물에 관한 것이다.The present invention relates to a functional beverage composition containing taurine, inositol, vitamin C, vitamin B group and potassium iodide as main components.
특히 본 발명은 타우린, 이노시톨, 비타민 C, 비타민 B군 (비타민 B1, 비타민 B2, 니코틴산아미드 등) 및 요오드화 칼륨을 함유하는 기능성 음료조성물로서 여기에 보조성분으로서 감미제, 유기산 점도조절제, 향료, 보존제, 식이섬유 및 과일주스에서 선택된 1종이상을 더 함유하는 기능성 음료조성물을 제공하는 것이다. 본 발명의 기능성 음료조성물은 간기능 장해 및 혈중 지질변화 개선작용이 있어 체내 유해물질을 제거하는 해독작용 및 혈중 콜레스테롤 저하, 간기능을 강화시키고 항산화 기능 및 두뇌 발달, 시각능력을 향상까지 확인된 타우린, 우리몸에 꼭 필요한 원소이며 갑상선 호르몬인 티록신과 티록신 유도체를 형성하는 과정에 필수성분인 요오드는 핵분열 생성시 발생하는 암유발 방사성 원소인 요오드 131(131I)의 흡수를 억제하는데 필수적인 방사성 물질이 아닌 요오드화칼륨, 강력한 항산화제로서 피부미백, 피부미용에 큰 도움을 주는 비타민 C와 항피로, 정상적인 발육과 영양분들에 필수 불가결한 미량의 물질의 통칭인 비타민 B군 등이 합리적으로 배합된 것을 특징으로 하는 방사능 관련 해독 기능을 보강한 기능성 음료조성물을 제공하는 것이다.
In particular, the present invention is a functional beverage composition containing taurine, inositol, vitamin C, vitamin B group (vitamin B1, vitamin B2, nicotinic acid amide, etc.) and potassium iodide, and as a secondary component, sweetener, organic acid viscosity regulator, flavoring agent, preservative, It is to provide a functional beverage composition further containing one or more selected from dietary fiber and fruit juice. The functional beverage composition of the present invention has the effect of improving liver function disorders and blood lipid changes, thus removing toxic substances in the body and detoxifying blood cholesterol, lowering blood cholesterol, enhancing liver function and improving antioxidant function and brain development, and visual ability. In addition, iodine, an essential element in our body and essential for the formation of thyroid hormones thyroxine and thyroxine derivatives, is a radioactive substance essential for inhibiting the absorption of iodine 131 ( 131 I), a cancer-causing radioactive element that occurs during fission production. Potassium iodide, vitamin C and anti-fatigue, which is a powerful antioxidant, helps to whiten the skin and helps skin beauty, and it is reasonably formulated with vitamin B group, which is a collective name of trace substances indispensable for normal development and nutrients. It is to provide a functional beverage composition with a radioactive detoxification function.
타우린 (taurine; 2-amino-ethanesulfonic aicd)은 포유동물의 체내에서 생합성되는 함황 아미노산 (sulfonic aminoacid)의 하나로서 세포 내액에서 유리된 상태로 존재하고, 특히 뇌, 안구, 근육, 간 등의 골격근과 신경계의 유리 아미노산 집단에서 높은 농도로 발견되며, 해독과 항산화 작용을 통해 간 기능 강화와 혈중 콜레스테롤 수치 감소 및 혈압조절 등 다양한 기능성을 가진 건강 소재로 오래 전부터 식품 및 음료에 사용되어 왔다. 타우린은 육식동물 체내에서 담즙산을 포합하여 타우로콜산 (taurocholic acid)의 형태로 담즙을 통해 배출되는데, 담즙으로 배출된 타우린은 계면활성 작용에 의해 장내에서 지방 또는 지용성 비타민의 흡수를 촉진시키고, 또한 이담작용에 의해 급성 간염시 황달의 경감 작용과 고지혈증 환자의 혈청 내 중성지방과 콜레스테롤의 수치를 저하시키는 효과가 있으며, 이외에도 뇌의 발육, 망막의 광수용체 활성, 생식 및 정상적인 성장 발달, 항산화 활성, 신경 전달 등 다양한 기능을 가지고 있는 것으로 보고되고 있다 (Jacobsen et al., Physiol. Rev . 48:424-511, 1968). 이와 같은 생리활성으로 인해 타우린은 유아용 이유식이나 껌, 음료 및 자양강장 드링크제 등의 각종 건강식품이나 의약품의 첨가물로 사용되고 있으나 약물로서는 자주 사용되지 않으며, 치료적 사용은 심장 질환의 치료에 대해서만 보고되어 있다.Taurine (taurine; 2-amino-ethanesulfonic aicd) is one of the sulfuric acid amino acids biosynthesized in the body of mammals and exists freely in intracellular fluid, especially skeletal muscles of the brain, eye, muscle, liver, etc. It is found in high concentrations in the free amino acid family of the nervous system, and has been used in food and beverages for a long time as a healthy material with various functions such as strengthening liver function, reducing blood cholesterol level and controlling blood pressure through detoxification and antioxidant activity. Taurine contains bile acids in the carnivorous body and is excreted through bile in the form of taurocholic acid.Taurine released into bile promotes the absorption of fat or fat-soluble vitamins in the intestine by interfacial action. It has the effect of reducing jaundice during acute hepatitis and lowering the level of triglyceride and cholesterol in serum of hyperlipidemic patients. In addition to this, brain development, retinal photoreceptor activity, reproductive and normal growth development, antioxidant activity, It has been reported to have various functions such as neurotransmission (Jacobsen et al., Physiol. Rev. 48: 424-511, 1968). Because of this physiological activity, taurine is used as an additive to various health foods and medicines, such as baby food, gum, beverages, and nourishing tonic drinks, but it is not frequently used as a drug, and therapeutic use is reported only for the treatment of heart disease. .
포유류의 조직에서 타우린은 함황 아미노산인 시스테인 (cysteine)과 메티오닌 (methionine)으로부터 생합성되는데, 인체의 경우 타우린의 생합성에 관여하는 시스테인 다이옥시게나제 (cysteine dioxygenase)와 시스테인 디카복실라제 (cysteine decarboxylase)의 활성이 매우 낮아 타우린의 생합성이 거의 이루어지지 않고 있으며 따라서 외부로부터 타우린을 공급받아야 한다 (Vinton et al ., Pediatr. Res . 21:399-403, 1987). 타우린(β-amino ethane sulfonate, taurine, MW 125)은 대부분의 동물조직 내에 가장 풍부하게 존재하는 유리 아미노산으로 골격근과 심장근, 뇌하수체, 혈소판, 림프아세포, 신장 및 망막에 고농도로 분포한다. 타우린은 망막의 광수용체 활성, 담즙산 포합, 백혈구의 항산화 활성, 폐의 항산화 활성, 중추신경계의 억제적 신경조절, 혈소판 응집의 감소, 심장수축의 촉진, 정세포 운동력 촉진, 인슐린작용 촉진, 임파구의 세포분화, 삼투압 조절, 세포증식, 칼슘의 유입과 유출, 당대사 촉진, 해독작용 및 세포막 안전성과 망막색소 상피세포의 증식촉진 등을 포함하는 광범위한 생물학적 기능을 담당한다.In mammalian tissues, taurine is biosynthesized from the sulfur-containing amino acids cysteine and methionine.In the human body, the activity of cysteine dioxygenase and cysteine decarboxylase is involved in the biosynthesis of taurine. This very low biosynthesis of taurine is rarely achieved and must be supplied from outside (Vinton et al., Pediatr. Res. 21: 399-403, 1987). Taurine (β-amino ethane sulfonate, taurine, MW 125) is the most abundant free amino acid in most animal tissues and is distributed in high concentrations in skeletal muscle, heart muscle, pituitary gland, platelets, lymphocytes, kidneys and retina. Taurine has photoreceptor activity in the retina, bile acid inclusions, antioxidant activity in the white blood cells, antioxidant activity in the lungs, inhibitory neuroregulation of the central nervous system, reduction of platelet aggregation, promotion of heart contraction, promotion of sperm cell activity, promotion of insulin action, lymphocyte cells. It is responsible for a wide range of biological functions, including differentiation, osmotic pressure control, cell proliferation, calcium inflow and outflow, promotion of glucose metabolism, detoxification and cell membrane safety and the promotion of retinal pigment epithelial cells.
타우린의 생체내 합성은 황 함유 아미노산인 메티오닌(methionine)과 시스테인(cysteine)의 대사로부터 유도되는 전이-황화(trans-sulfuration) 과정에 의해 주로 이루어지며 함유 아미노산의 최종산물이다. 상기 타우린의 합성과정은 시스테인(cysteine)의 시스테인설피닉산(cysteinesulfinic acid)으로의 산화, 히포타우린(hypotaurine)으로의 탈탄산 및 타우린으로의 산화가 주된 경로를 이루고 있다. 이때, 시스테인의 히포타우린으로의 탈탄산에 중요한 효소로 작용하는 시스테인설피닉산 탈탄산효소(cysteinesulfinic acid decarboxylase, CSAD)는 함유 아미노산 대사에 중요한 시스타치온 합성효소(cystathione synthase), 시스타치오나제(cystathionase), 시스테인 이산화효소(cysteine dioxygenase)와 함께 비타민 B 6 (Vitamin B 6 )의 농도에 크게 의존한다. 따라서, 비타민 B6 의 결핍은 타우린의 생합성에 영향을 미치게 되고 타우린의 소변 중 배설량도 감소시킨다.In vivo synthesis of taurine is achieved primarily by a trans-sulfuration process derived from the metabolism of sulfur containing amino acids methionine and cysteine and is the end product of amino acids. Synthesis of the taurine is mainly composed of the oxidation of cysteine to cysteinesulfinic acid, decarboxylation to hypopotrine, and oxidation to taurine. At this time, cysteinesulfinic acid decarboxylase (CSAD), which acts as an important enzyme for decarboxylation of cysteine to hippourin, is a cystathione synthase and cystathionase, which are important for metabolizing amino acids. ), Along with cysteine dioxygenase, strongly depend on the concentration of vitamin B 6 (Vitamin B 6). Thus, deficiency of vitamin B6 affects the biosynthesis of taurine and reduces the excretion of taurine in urine.
인간에게 있어 타우린의 생합성에 관련된 상기 효소들의 활성은 고양이를 제외한 다른 동물에 비하여 매우 낮을 뿐만 아니라 미숙아와 신생아일 경우에는 타우린의 체내 생합성 시스템이 완전하게 발달되지 못하여 타우린의 생합성이 매우 제한적이다. 특히, 미숙아와 신생아는 타우린 생합성 관련 효소 중에서 시스테인 이산화효소와 시스테인 설핀산 탈탄산효소의 활성이 매우 낮아 정상적인 타우린의 생합성이 불가능하므로 미숙아와 신생아에게는 시스테인이나 타우린을 필수영양소로서 외부에서 공급해주어야 한다. 또한, 장기간 중심정맥영양상태의 환자들도 TPN(total parenteral nutrition) 제제중에 타우린을 추가로 첨가하여 공급하지 않으면 저타우린혈증 및 저타우린뇨증과 같은 타우린 결핍이 발생한다. 상기와 같이 체내 조건적 필수 아미노산으로서 매우 중요한 생물학적 기능을 담당하는 타우린의 결핍은 삼투압조절, 세포증식, 칼슘의 유입과 유출, 당 대사촉진, 신경흥분성 조절, 해독작용 및 세포막 안전성과 망막색소 상피세포 증식촉진 등의 기능에 문제를 일으켜 여러 가지 합병증을 유발한다.
In humans, the activity of the enzymes involved in taurine biosynthesis is not only very low compared to other animals except cats, but in premature infants and newborns, taurine biosynthesis system is not fully developed, so taurine biosynthesis is very limited. In particular, premature infants and newborns have low activity of cysteine dioxide and cysteine sulfinic acid decarboxylase among taurine biosynthesis-related enzymes, so that normal taurine biosynthesis is impossible. Therefore, premature infants and newborns should be supplied with cysteine or taurine as essential nutrients from outside. In addition, patients with long-term central venous nutrition develop taurine deficiency, such as hypotaurine and hypotaurineuria, unless additional taurine is added to the total parenteral nutrition (TPN) preparation. As described above, the deficiency of taurine, which plays a very important biological function as a conditionally essential amino acid in the body, is osmotic pressure regulation, cell proliferation, calcium inflow and outflow, glucose metabolism promotion, neuroexcitatory regulation, detoxification and membrane safety and retinal pigment epithelial cells. It causes problems such as growth promotion and causes various complications.
타우린은 아미노산의 일종으로 새우, 오징어, 문어, 조개류 등과 갑각류 및 연체동물에 많이 함유되어 있으며, 주된 생리작용은 담즙생성, 콜레스테롤의 농도조절, 이온의 세포막투과조절, 항산화작용, 과도한 신경흥분억제작용이 있으며, 체액보다는 심장과 골격근, 뇌, 생식기관의 세포 등에 많이 함유되어 있다. 타우린은 심장의 칼륨이온 농도가 정상보다 낮을 때 심장의 수축력을 약화시킴으로 강심작용이 있는 것으로 알려져 있으며, 담즙산과 중합체를 형성하여 담즙산의 독성을 완화하고 장에서 지방흡수를 돕는다. 한편 카테콜아민이 지방조직을 분해하는 과정에 관여하여 지방대사를 촉진하며, 콜레스테롤과 중성지방을 감소시켜 혈압을 정상으로 유지하므로 동맥경화, 고혈압, 뇌졸중, 심부전등의 성인병에도 효과가 있는 것으로 알려져 있다. 세포막에서는 과산화물과 질소산화물, 후리라디칼이 세포막에 손상을 주기 전에 제거함으로 세포를 보호한다. 타우린은 뇌에 들어 있는 아미노산중 농도가 가장 높으며, 신경이 지속적으로 흥분될 때 과도한 신경흥분을 억제하여 신경 안정효과도 있는 것으로 알려져 있다. Taurine is a kind of amino acid and is contained in shrimp, squid, octopus, shellfish and other shellfish and mollusks. The main physiological functions are bile formation, cholesterol concentration control, ion permeability, antioxidant activity, and excessive neurostimulation. There is a lot of body fluids, such as heart and skeletal muscle, brain, reproductive organs, etc. are contained. Taurine is known to have a cardiac effect by weakening the contractile force of the heart when the potassium ion concentration in the heart is lower than normal, and forms bile acids and polymers to reduce the toxicity of bile acids and help absorb fat in the intestines. On the other hand, catecholamines are involved in the process of decomposing adipose tissue, promote fat metabolism, reduce cholesterol and triglycerides to maintain normal blood pressure, so it is known to be effective in adult diseases such as atherosclerosis, hypertension, stroke, heart failure. Cell membranes protect cells by removing peroxides, nitrogen oxides and free radicals before damaging them. Taurine has the highest concentration of amino acids in the brain, and is known to have a nerve stabilizing effect by inhibiting excessive excitement when nerves are constantly excited.
요오드화칼륨은 요오드와 칼륨의 화합물이며 요오드화칼륨 화합물 중에서 가장 상업적을 중요한 무기화합물이다.Potassium iodide is a compound of iodine and potassium and is the most commercially important inorganic compound among potassium iodide compounds.
요오드화칼륨은 요오드칼리라고도 한다. 화학식 KI이며, 무색 투명한 결정 또는 흰색 결정형 분말로 냄새가 없다. 녹는점 723, 끊는점 1,330, 비중 3.12이다. 물에 잘 녹아 20의 물 100g에 144g이 녹는다. 이 반응은 흡열반응이다. 수용액은 중성 또는 약간의 알카리성을 보인다. 수용액에 브로민, ,발연질산(潑煙窒酸), 염화백금, 염화철, 진한황산, 클로라민 등을 작용시켜면 요오드을 유리한다. 질산은을 가하면 요오드화은이, 아세트산납을 가하면 노란색의 요도드화납이 각각 침전한다. 순수한 것은 공기 중에서 변하지 않지만, 일반적으로 미량(黴量)의 요오드화산칼륨(KIO3 )을 함유하면, 햇빛과 공기중의 이산화탄소의 작용에 의해서 아이오딘을 유리한다. 소량의 알칼리를 섞으면 유리(遊離)요오드에 의한 착색을 방지할 수 있다. 알코올, 액체 암모니아에도 녹는다.Potassium iodide is also known as iodide. Formula KI, colorless transparent crystals or white crystalline powder, odorless It has a melting point of 723, a breaking point of 1,330 and a specific gravity of 3.12. Soluble in water, 144g in 100g of 20 water. This reaction is an endothermic reaction. The aqueous solution is neutral or slightly alkaline. Iodine is advantageous when bromine, fuming nitric acid, platinum chloride, iron chloride, concentrated sulfuric acid, and chloramine are applied to the aqueous solution. When silver nitrate is added, silver iodide precipitates, and when lead acetate is added, yellow lead iodide precipitates. Pure water does not change in air, but generally contains trace amounts of potassium iodide (KIO 3 ) , which favors iodine by the action of sunlight and carbon dioxide in the air. Mixing a small amount of alkali can prevent coloring by free iodine. Soluble in alcohol and liquid ammonia.
요오드화칼륨은 실험실에서는 수산화칼륨 용액에 요요드을 작용시켜, 증발한 다음 부생(副生)하는 요오드화칼륨에 목탄(C)를 가하고 끓여서 환원시켜 농축하여 만든다. 또한 순순한 것을 얻는 데에는 요오드화수소의 수용액과 탄산수소칼륨을 수소기류 속에서 반응시킨다.Potassium iodide is made by applying iodine to potassium hydroxide solution in a laboratory, evaporating, adding charcoal (C) to by-product potassium iodide, boiling, reducing it, and concentrating. In addition, to obtain a pure thing, an aqueous solution of hydrogen iodide and potassium hydrogen carbonate are reacted in a hydrogen stream.
공업적으로 철가루(또는 파쇠)Fe에 물 또는 0.5%의 요오드화칼륨 수용액을 가하고, 요오드을 조금씩 가하여 요오드화철을 만든다. 이 반응액을 조용히 두었다가 잔류하는 철분을 제거하고, 탄산칼륨 KCO3를 작용시키면 생긴다. 요오드는 체내의 신진대사를 촉진시키는 작용이 있어, 의약품으로서 만성관절염렇맑볜馝蕁셉脂신경통렇맑볍釜潭森떱매독 등에 사용되고, 요오드 화합물의 원료로도 사용된다.
Industrially, iron or iron (Fe) Fe is added with water or 0.5% aqueous potassium iodide solution, and iodine is added little by little to form iron iodide. This reaction liquid is kept quiet, the remaining iron is removed, and potassium carbonate KCO 3 is produced. Iodine has a function of promoting metabolism in the body, and is used as a medicine for chronic arthritis, neuralgia, and light syphilis, and also as a raw material for iodine compounds.
우리 몸은 요오드를 필요로 하지만, 불행히도 안정한 방사선을 방출하지 않는 일반적인 요오드(127I) 과 해로운 방사능 요오드인 131I을 구별하지 못하고 흡수한다. 기체로 된 127I 는 호흡을 통해서도 쉽게 우리 몸에 들어온다. 일상에서 음식을 통해 몸으로 흡수된 요오드는 갑상선 호르몬을 만드는데 이용된다. 갑상선 호르몬인 티록신과 티록신 유도체를 형성하는 과정에는 요요드가 필수적으로 들어간다. 이들 갑성선 호르몬들은 대사과정에 관여하며 거의 모든 세포에 영향을 미치므로 요오드는 반드시 섭취해야만 되는 화학물질인 것이다.Your body needs iodine, but unfortunately it does not distinguish between ordinary iodine ( 127 I), which does not emit stable radiation, and 131 I, a harmful radioactive iodine. 127 I in gas easily enters our bodies through breathing. Iodine, which is absorbed into the body through food in everyday life, is used to make thyroid hormones. Iodine is essential for the formation of thyroid hormones thyroxine and thyroxine derivatives. These thyroid hormones are involved in metabolism and affect almost all cells, so iodine is a chemical that must be consumed.
방사능 131I 도 흡수되면 갑상선에 축적이 되고, 131I 이 방출하는 베타선을 쪼인 갑상선 세포들은 나중에 암으로 발전하는 것이다. 그러므로 핵분열 원조 중에 암 유발을 잘하는 물질로 꼽는 것이 131I 이다. 그런데 131I 이 흡수되는 것을 막으려면 미리 요오드이 포함된 화학물질(예; Kl, 아이오딘 칼륨 혹은 요오드화 칼륨)을 해독제로 먹는다. 우리 몸에 이미 많은 양의 안정한 요오드(127I)이 있으니 131I 이 포함되어 오염이 전파될 가능성도 배제할 수 없다. 다행히 요오드이 다른 분자와 화학결합을 하면 고정이 되겠지만 여전히 위험은 내포하고 있다. 해독제로 필요한 요오드는 약 130밀리그람 정도이지만, 평소에 필요한 요오드는 하루에 약2밀리그램 정도이다.
Absorption of radioactive 131 I also accumulates in the thyroid gland, and thyroid cells that have been beta-lined by the 131 I release later develop cancer. Therefore, 131 I is one of the fission aids that causes cancer well. However, to prevent the absorption of 131 I, iodine-containing chemicals (such as Kl, potassium iodine or potassium iodide) are taken as antidote. Since there is already a large amount of stable iodine ( 127 I) in our bodies, it is impossible to rule out the possibility of contamination spreading because it contains 131 I. Fortunately, if iodine chemically bonds with another molecule, it will be fixed, but it still poses a risk. Iodine is about 130 milligrams of antidotes, but iodine is about 2 milligrams a day.
방사선 피록시, 방사선요오드는 공기로 방출되어 호흡, 음식물, 음료등을 통해 체내로 들어와 갑상선에 의해 빠르게 흡수되어 갑상선을 파괴한다. 이때 요오드화칼륨을 복용하게 되면 방사선요오드대신 비 방사선요오드가 갑상선에 축적되므로서 방사선요오드의 흡수를 억제하고 결과적으로 소변으로 배설하거나 배설을 촉진하게 된다. 따라서 방사선 노출전, 후 1~2시간에 요오드화칼륨을 복용하면 방사선요오드화칼륨에 의한 갑상선암 발생 위험성을 감소시키거나 예방하는 효과가 있다.
Radiation Pyrroxy and radioiodine are released into the air and enter the body through breathing, food, and beverages and are quickly absorbed by the thyroid gland and destroy the thyroid gland. At this time, taking potassium iodide, non-radioactive iodine accumulates in the thyroid gland instead of radioactive iodine, thereby suppressing the absorption of radioactive iodine and consequently excreting it in urine or promoting excretion. Therefore, taking potassium iodide 1 to 2 hours before and after radiation exposure has the effect of reducing or preventing the risk of thyroid cancer caused by potassium iodide.
지금까지 요오드화 칼륨을 주성분으로 함유하는 기능성 음료는 개발된 바 없다.
To date, no functional beverage containing potassium iodide as a main ingredient has been developed.
비타민 C는 몸의 노화와 질병을 막는 강력한 항산화제다. 비타민 C의 효과를 이야기할 때 자주 언급되는 것 중 하나가 항산화 작용이다. 말 그대로 어떤 물질이 산화되는 것을 막아주는 역할을 뜻한다. 철이 산화되면 녹이 슬듯이 인체도 산화를 유발하는 물질을 만나 이들의 공격을 받으면 제 모습을 잃어버리고 병들게 된다. 이를 막아주는 것이 바로 비타민 C와 같은 항산화제들이 하는 일이다. 사람 몸속의 세포 내에는 에너지를 공급하는 미토콘드리아가 존재하는데, 이 미토콘드리아는 세포가 정상적인 활동을 할 수 있도록 에너지를 공급하는 역할을 한다. 이 에너지를 만드는 과정에서 부수적으로 활성산소와 자유기라 불리는 오염물질들이 발생한다. 문제는 오염으로 범벅이 되고 자연이 병들어 있는 현대사회에서는 인체 내에 자연적으로 존재하는 항산화제만으로 오염물질들을 완전히 처리해낼 수 없다는 점이다. 나이가 들거나, 유해 환경에 처해 있거나, 약물을 자주 오랫동안 복용하게 되면 오염물질 들과 싸울 항산화제의 양이 더욱 줄어들게 된다. 바로 이 싸움에 가장 크고 강력한 도움을 줄 수 있는 것이 비타민 C이다. 비타민 C가 오염물질들에 몸을 던져 자신을 산화시키고 세포 속을 정화시킴으로써 우리 몸을 지켜낸다고 한다. 또한 다른 항산화제가 고용량에서 부작용을 일으킬 수 있는 반면, 비타민 C는 초고용량에서도 몸에 해를 끼치지 않는 안전한 항산화제라고 강조할 수 있다. 아무리 많은 양을 공급해도 그 사람의 몸에서 필요한 만큼 쓰이고 난 뒤에는 모두 몸 밖으로 빠져나가기 때문에, 남아서 부작용을 일으키는 항산화제들과는 다르다는 것이 비타민 C의 가장 큰 장점이다.Vitamin C is a powerful antioxidant that helps prevent aging and disease in the body. One of the things often mentioned when talking about the effects of vitamin C is antioxidant activity. Literally means to prevent the oxidation of any substance. When iron is oxidized, the human body also encounters substances that cause oxidation, and when they are attacked, they lose their appearance and become sick. That's what antioxidants like vitamin C do. There is a mitochondria that supplies energy in the cells of the human body. The mitochondria provide energy for the cells to perform their normal activities. Incidentally, in the process of making this energy, pollutants called free radicals and free radicals are generated. The problem is that in modern societies that are engulfed by pollution and diseased by nature, antioxidants that are naturally present in the human body cannot completely dispose of the pollutants. Getting older, being in a hazardous environment, or taking drugs for a long time often reduces the amount of antioxidants that fight off pollutants. The biggest and most powerful help in this fight is vitamin C. Vitamin C is said to protect our bodies by throwing bodies into pollutants to oxidize themselves and purify our cells. While other antioxidants can cause side effects at high doses, it can be emphasized that vitamin C is a safe antioxidant that does not harm your body even at very high doses. The biggest benefit of vitamin C is that it is different from the antioxidants that remain and cause side effects, because no matter how much you supply, it will go out of your body after it's used as needed by your body.
비타민 C는 콜라겐의 합성 및 카르니틴의 생합성 및 면역기능에 관여하는 비타민으로서 활성산소와 연계하며 특히 주목되는 항산화제 작용이 있다.
Vitamin C is a vitamin involved in the synthesis of collagen and the biosynthesis and immune function of carnitine. It is associated with free radicals and has a particularly noticeable antioxidant action.
항산화 작용과 직결되는 활성산소란 원래 인간을 비롯한 동, 식물의 체내에 있으면서 곰팡이. 바이러스, 이물질 등이 체내에 지나치게 증가되며 오히려 자기 몸의 조직을 공격하는 양면성을 지니고 있다. 따라서 우리 몸 안에는 체내에서 생성된 유해한 활성산소를 제거하기 위해 항산화벽 (항산화 방어 메카니즘)이 존재한다. 즉 인간의 체내에는 SOD (수퍼옥시드디스뮤타제) 같은 효소를 비롯해 각종 항산화물질이 존재해 활성산소의 공격으로부터 인체를 방어해주고 있다. 더 자세하게 세포안에서는 셀레늄과 글루타치온으로 만들어지는 글루타치온 페록시다제와 아연, 구리, 망간 등을 필요로 하는 SOD라고 불리우는 수퍼옥시드디스뮤타제, 카탈라아제 효소에 의해 활성산소가 제거된다. 통상 우리가 호흡하는 산소의 2-5% 정도는 활성산소로 바뀌어지는데 문제가 되는 것을 인체 내 항산화벽을 뛰어넘을 정도로 생성되는 과잉현상이다. 이의 원인으로 1) 스트레스 2) 자외선 3) 방사선 4) 화학물질 (농약, 살충제, 의약품, 질소 화합물) 5) 과격한 운동 (힘든 육체노동), 과식, 음주, 흡연 6) 각종 공해 등이다. 현대의 과도한 스트레스의 환경에서는 생체 내 활성 산소의 생성과 제거의 균형이 많이 깨지고 있어 스트레스를 해소시켜주거나 또는 항산화 성분이나 항산화 성분 생성에 필요한 미네랄 성분을 외부로부터 보급해주는 것이 아주 중요하다. 한편, 신경을 안정시켜 스트레스 해소에 도움을 주는 칼슘 등의 성분을 섭취해주는 것도 중요하다. 한편, 신경을 안정시켜 스트레스 해소에 도움을 주는 칼슘 등의 성분을 섭취해주는 것도 아주 중요하다. Free radicals, which are directly linked to antioxidant activity, are fungi that exist in the body of animals, animals, and plants. Viruses, foreign objects, etc. are excessively increased in the body and rather have a double-sided attack on the body's tissues. Therefore, there is an antioxidant wall (antioxidant defense mechanism) in our body to remove harmful free radicals produced in the body. In other words, enzymes such as SOD (superoxide dismutase) and other antioxidants are present in the human body to protect the body from attack of free radicals. More specifically, within the cell, free radicals are removed by glutathione peroxidase, made of selenium and glutathione, and by superoxide dismutase and catalase enzymes called SODs that require zinc, copper, and manganese. Normally, 2-5% of the oxygen we breathe is a surplus that exceeds the antioxidant walls in the body, causing the problem of turning into free radicals. This can be caused by: 1) stress, 2) ultraviolet radiation, 3) radiation, 4) chemicals (pesticides, pesticides, medicines, and nitrogen compounds), 5) intense exercise (hard physical labor), overeating, drinking, smoking, and 6) pollution. In the modern environment of excessive stress, the balance between the generation and removal of free radicals in the living body is broken so that it is very important to relieve stress or to disperse the minerals necessary for the production of antioxidants or antioxidants from the outside. On the other hand, it is also important to eat ingredients such as calcium to stabilize the nerves to help relieve stress. On the other hand, it is also very important to eat ingredients such as calcium to stabilize the nerves to help relieve stress.
비타민B군은 우리 몸에 필수적인 3대 영양소, 즉 탄수화물, 단백질 및 지방의 대사에 조효소로 작용하는 역할을 한다. 1. 비타민B군은 다른 비타민들과 마찬 가지로 대부분의 몸조직에서 코엔자임(생화학 반응 시 촉매작용을 함)으로 사용된다. 2. 단백질, 지방, 특히, 탄수화물의 대사에 필수적 역할을 한다. 3. 피부, 눈, 간, 입, 머리카락 등의 조직 기능에 필수적이서 각종 피부문제, 입병, 입 주위가 헐거나 갈라지는 증상, 눈 불편함 등의 증상에 많이 사용된다. 4. 에너지 발생과정에서 필수적인 역할을 하므로 에너지 비타민으로 불려지기도 함. 복용 후 피로감이 사라지는 경험을 많이 한다. 5. 어린이들의 성장에 중요한 역할을 함. 어린이, 임산부들에게 더 많이 필요하며, 스트레스 시, 각종 감염증시에도 필요량이 증가한다. 6. 어린이 식욕증가에 도움이 된다는 보고도 있다. 7. 뇌, 신경계에의 역할은 여러 연구조사 및 실험을 통해 확인되어 많은 전문가들이 우울증, 신경증, 짜증, 기억력 감퇴 등의 증상에 비타민B콤플렉스를 사용하고 있다. 8. 스트레스 저항력, 면역력 강화, 에너지를 강화하는 효과 있음. 많은 사람들이 고단위 비타민 B콤플렉스를 복용한 후 에너지와 활력이 증가하는 것을 경험한다. 9. 비타민B콤플렉스는 혈중 호모시스틴을 낮추는 기능이 있어 호모시스틴이 야기하는 여러 가지 질병으로부터 우리를 지켜준다.B vitamins act as coenzymes in the metabolism of the three major nutrients essential for our body: carbohydrates, proteins and fats. B vitamins, like other vitamins, are used in most body tissues as coenzymes (catalysis in biochemical reactions). 2. Plays an essential role in the metabolism of proteins, fats, especially carbohydrates. 3. It is essential for the tissue function of skin, eyes, liver, mouth, hair, etc., and it is used for various skin problems, sickness, symptoms such as breakage or splitting around the mouth, and eye discomfort. 4. It is also called as an energy vitamin because it plays an essential role in the energy generation process. Have a lot of experience with fatigue after taking it. 5. Plays an important role in the growth of children. More needs are given to children and pregnant women, and stress, the need for various infections increases. 6. It has been reported to help increase appetite in children. 7. The role of the brain and nervous system has been confirmed by various studies and experiments, and many experts use vitamin B complex for symptoms such as depression, neurosis, irritability and memory loss. 8. Stress resistance, immunity strengthening, energy strengthening effect. Many people experience increased energy and vitality after taking the high-vitamin B complex. 9. Vitamin B complex lowers homocystine in the blood and protects us from various diseases caused by homocystine.
비타민 B군에는 비타민 B1 (치아민), B2 (리보플라빈), B3 (니코틴산아미드), B5 (판토텐산), B6 (피리독신), B12 (코발라민) 등이 있다. 비타민B1 (Thiamin: 티아민)은 탄수화물대사에 필수, 운동 및 스트레스 등 신진대사가 증가할 때 필요량 증가, 알콜의 분해시 필요. 미국인들이 숙취해소 용도로 많이 복용, 뇌등 중추신경계와 관련이 깊다. 비타민B2 (Riboflavin: 리보플라빈)은 눈 건강에 필수. 눈물과다, 눈피로, 시력문제 등에 도움이 될 수 있음, 구순염 (입 주위 갈라지는 병)에도 효과 있다. 비타민B3 (Niacin: 나이아신 or Niacinamide: 나이아신아미드)는 콜레스테롤, 지방 감소, 혈액순환 증가 효과, 많은 실험에서 혈중 콜레스테롤(LDL)과 중성지방을 낮추는 효과가 있음이 증명, 한 실험에서는 콜레스테롤 낮추는 약보다 더 효과가 큰 것으로 나타나기도 했음, 혈관을 확장시키는 기능도 있어 각종 혈액순환문제에 많이 사용, B3의 다른 형태인 나이아신아미드 (Niacinamide)는 이러한 효과가 없으며, 니코틴산 (Nicotinic acid, 나이아신) 형태만 이러한 효과가 있음, 나이아신은 피부 (얼굴포함)가 일시적으로 붉어지는(Flush) 부작용이 있을 수 있다. 또한 신경계 질환 및 우울증, 짜증, 기억력 감퇴에도 도움이 된다. The vitamin B group includes vitamin B1 (chiamine), B2 (riboflavin), B3 (nicotinamide), B5 (pantothenic acid), B6 (pyridoxine), and B12 (cobalamin). Vitamin B1 (Thiamin) is essential for carbohydrate metabolism. Increases the amount needed for metabolism such as exercise and stress. Americans take a lot of hangovers to relieve the central nervous system, such as the brain. Vitamin B2 (Riboflavin) is essential for eye health. May be helpful for excessive tears, eye strain, vision problems, etc. Vitamin B3 (Niacin: Niacinamide or Niacinamide) has been shown to lower cholesterol, reduce fat, increase blood circulation, and lower blood cholesterol (LDL) and triglycerides in many experiments. It has been shown to have great effects, and it has a function of expanding blood vessels, so it is widely used for various blood circulation problems. Another form of B3, niacinamide, has no such effect, and only nicotinic acid (niacin) form has such an effect. With niacin, there may be side effects that the skin (including the face) temporarily flushes. It also helps with nervous system disorders, depression, irritability and memory loss.
캐나다의 Abram Hoffer 박사(정신과 의사)는 정신분열증 (Schizophrenia) 환자에 나이아신을 매일 1,000mg이상 복용시킨 결과 상태가 호전됨을 확인함. 이는 일일권장량의 50배에 해당하는 양임. 그는 나이아신의 이러한 효과를 확신하고 많은 정신질환자들에게 효과적으로 사용하였으며 이러한 증상에 오메가3지방산과 함께 섭취하면 시너지효과 있다. 2개의 연구실험에서 하루 200mg의 나이아신이 실험대상의 90% 에게 생리통 완화효과를 준 것으로 나타났다. Abram Hoffer, a Canadian psychiatrist, found that patients with schizophrenia had better than 1,000 mg of niacin daily. This is 50 times the recommended daily amount. He is convinced of this effect of niacin and has used it effectively for many mentally ill people. It is synergistic when taken with omega-3 fatty acids. Two studies showed that 200 mg of niacin a day relieved menstrual cramps in 90% of subjects.
이와 같이 비타민 B군은 대사기능을 수행하기 위하여 인체 내에 발생되는 여러 가지 생리작용을 원활하게 하는 효소를 만드는 중요한 역할을 하며 생체내 에너지 대사에 깊이 관여하는 구성성분들로서 일상생활에 있어서 스트레스, 피로감을 자주 느끼는 지친 현대인들의 건강관리에 필수적인 영양소로 되어 있다. 주요 비타민 B군의 기능과 관련이 있는 식품은 다음의 같다.As such, the vitamin B group plays an important role in making enzymes that facilitate various physiological effects in the human body to perform metabolic functions, and is a component that is deeply involved in energy metabolism in the living body, causing stress and fatigue in everyday life. It is a nutrient essential for the health care of tired and tired modern people. Foods related to the function of the major vitamin B group are as follows.
(mg)Optimum Daily Intake
(mg)
전효소, 신경기능, 피로물질 축적 방지Carbohydrate metabolism
Prevention of accumulation of whole enzyme, nerve function and fatigue substance
각기병, 부종Fatigue, weakness,
Keratosis, edema
해바라기씨Pork, Peas
Sunflower seeds
눈의 피로 및 입병 개선Coenzymes of energy metabolism,
Eye strain and illness improvement
눈 장애Inflammation of the mouth, tongue,
Eye disorders
이노시톨은 백색결정 또는 결정성 분말로 냄새는 없고 맛은 달며, 물에 잘 녹고(1g/7ml 물), 에탄올에는 거의 녹지 않으며, 에테르, 클로로포름에는 거의 녹지 않으며, 열, 산 및 알칼리에는 안정하다. 비환원성 결정화물로 열, 빛, 산 및 알칼리에 안정하며, 설탕의 50%정도의 단맛을 가지고 있다. 동물의 성장촉진, 항지방간 작용, 세포의 활성화 작용을 가지고 있다. 그 약리작용을 보면, 항지방간 작용 및 동맥경화 억제작용을 가진다. 지방간은 탄수화물의 대사장애, 고지방 저단백질 섭취, 고콜레스테롤 식품섭취, 알코올중독, 악성빈혈 및 갑상선 기능장애로 생기는 데 주로 C16~C18의 고급지방산의 글리세라이드인 지질과 콜레스테롤 에스테르의 혼합물이다. 따라서 지방간 축적을 방지하기 위하여 이노시톨을 섭취하면 이노시톨이 간에서 신속하게 포스파티딜 이노시톨(phosphatidyl inositol)로 변화해 베타-리포프로테인 생성을 높여주어 지질의 분비를 촉진하게 된다. 또한 동맥의 콜레스테롤 침착에 의한 동맥경화에도 이노시톨이 간에서와 같이 지질을 분해하므로 매우 효과적이다. 콜레스테롤증 환자에게 2-3g/day의 이노시톨을 투여하면, 혈액중의 콜레스테롤 함유량이 급격히 감소한다. Inositol is a white crystalline or crystalline powder that is odorless, tastes good, soluble in water (1 g / 7 ml water), insoluble in ethanol, insoluble in ether, chloroform, and stable to heat, acid and alkali. Non-reducing crystalline, stable to heat, light, acid and alkali, sweetness of about 50% of sugar. Has animal growth promoting, anti-fatty action, and cell activation. The pharmacological action has anti-fatty action and atherosclerosis suppression effect. Fatty liver is a mixture of lipid and cholesterol esters, a glyceride of C16-C18 higher fatty acids, caused by metabolic disorders of carbohydrates, high fat and low protein intake, high cholesterol food intake, alcoholism, pernicious anemia and thyroid dysfunction. Therefore, when inositol is ingested to prevent fatty liver accumulation, inositol is rapidly converted into phosphatidyl inositol in the liver to increase beta-lipoprotein production and promote lipid secretion. Inositol is also very effective in arteriosclerosis due to cholesterol deposition in arteries, as it breaks down lipids as in the liver. When 2-3 g / day of inositol is administered to a patient with cholesterol, the cholesterol content in the blood is drastically reduced.
또한 성장촉진작용도 한다. 이노시톨은 인간세포의 필수영양분으로 세포발육 및 성장에 관여하며 장내 세균발육을 도와서 체내 영양성분의 합성에 기여한다. 그 외에 미생물의 생육인자(bio-1-factor)로 특히 효모생육에는 반드시 필요한 성분이며, 또한 이노시톨은 칼슘흡수량을 증가시키며 혈당감소효과를 가지고 있으므로 영양학적 관점에서 식품첨가물로서의 이용가능성이 크며, 이노시톨은 천연 물질이므로 독성은 전혀 없다.
It also promotes growth. Inositol is an essential nutrient for human cells. It is involved in cell growth and growth, and contributes to the synthesis of nutrients in the body by helping intestinal bacterial growth. In addition, it is a bio-1-factor of microorganisms, which is essential for yeast growth.Inositol also increases calcium absorption and decreases blood sugar, so it is highly useful as a food additive from a nutritional point of view. Is a natural substance and therefore has no toxicity.
본 발명은 타우린, 이노시톨, 비타민 C, 비타민 B군 (비타민 B1, 비타민 B2, 니코틴산아미드)에 방사성 요오드 노출에 의한 갑상선암을 예방하거나 또는 그 발생율을 억제 및 감소시키는 요오드화칼륨을 배합한 기능성 음료조성물을 제공하는 것이며, 여기에 보조성분으로서 감미제, 유기산, 점도조절제, 향료, 보존제, 식이섬유 및 과일주스에서 선택된 1종이상을 더 함유하는 기능성 음료조성물을 제공하는 것이다.The present invention provides a functional beverage composition containing potassium iodide, which prevents or reduces and reduces the incidence of thyroid cancer caused by radioactive iodine exposure to taurine, inositol, vitamin C, and vitamin B group (vitamin B1, vitamin B2, nicotinamide). To provide a functional beverage composition further comprising at least one selected from sweeteners, organic acids, viscosity regulators, flavoring agents, preservatives, dietary fiber and fruit juice as an auxiliary component.
기능성 음료조성물에 요오드화칼륨을 함유하는 음료는 지금까지 개발된 바 없으며, 본 발명에 의하여 최초로 개발되어, 상용화되었으며, 본 발명의 기능성 음료를 섭취하여, 요오드 127을 섭취하면, 특히 일본의 대지진으로 인한 원자력발전소에서 유출되는 방사성 요드인 요오드 131의 체내 흡수를 방해하여 갑상선 암을 예방할 수 있는 이점이 있다.A beverage containing potassium iodide in the functional beverage composition has not been developed until now, and was first developed and commercialized according to the present invention, and when the functional beverage of the present invention is ingested, the intake of iodine 127 may be particularly caused by a major earthquake in Japan. There is an advantage that can prevent the thyroid cancer by preventing the absorption of iodine 131, the radioactive iodine emanating from the nuclear power plant.
타우린, 이노시톨, 비타민C 및 비타민 B군, 요오드화칼륨 주성분에 특성을 보강한 기능성 음료조성물에 관한 것이다.
The present invention relates to a functional beverage composition in which taurine, inositol, vitamin C and vitamin B groups, and potassium iodide main ingredients are reinforced.
특히 본 발명은 타우린, 이노시톨, 비타민 C, 비타민 B군 (비타민 B1, 비타민 B2, 니코틴산아미드 등 주성분에 요오드 칼륨을 함유 하는 기능성 음료조성물로서 여기에 보조성분으로서 감미제, 유기산 점도조절제, 향료, 보존제, 식이섬유 및 과일주스에서 선택된 1종 이상을 더 함유하는 기능성 음료조성물을 제공하는 것이다. 본 발명의 기능성 음료조성물은 간기능 장해 및 혈중 지질변화 개선작용이 있어 체내 유해물질을 제거하는 해독작용 및 혈중 콜레스테롤 저하, 간기능을 강화시키고 항산화 기능 및 두뇌 발달, 시각능력을 향상까지 확인된 타우린, 우리몸에 꼭 필요한 원소이며 갑상선 호르몬인 티록신과 티록신 유도체를 형성하는 과정에 필수성분인 요요드는 핵분열 생성시 발생하는 암유발 131I 흡수를 억제하는데 요오드를 포함된 요요오드화칼륨, 강력한 항산화제로서 피부미백, 피부미용에 큰 도움을 주는 비타민 C와 항피로, 정상적인 발육과 영양분들에 필수 불가결한 미량의 물질의 통칭인 비타민 B군 등이 합리적으로 배합된 것을 특징으로 하는 방사능 관련 해독 기능을 보강한 기능성 음료조성물을 제공하는 것이다.
In particular, the present invention is a functional beverage composition containing potassium iodine in main components such as taurine, inositol, vitamin C, and vitamin B group (vitamin B1, vitamin B2, nicotinic acid amide, etc.), and as a secondary component, sweeteners, organic acid viscosity regulators, flavoring agents, preservatives, It is to provide a functional beverage composition further comprising at least one selected from dietary fiber and fruit juice The functional beverage composition of the present invention has a liver function disorder and blood lipid change improvement action to remove harmful substances in the body and blood Taurine has been found to lower cholesterol, enhance liver function, improve antioxidant function and brain development, and improve vision.Yodine, an essential ingredient in the formation of thyroid hormones thyroxine and thyroxine derivatives, is an essential element in our body. the cancer to inhibit 131 I-absorbing generated including iodine I iodide It is a powerful antioxidant that is reasonably formulated with vitamin C and anti-fatigue, which is a great help for skin whitening and skin beauty, and the vitamin B group, which is a collective name of trace substances indispensable for normal development and nutrients. It is to provide a functional beverage composition with a radioactive detoxification function.
본 발명에서는 정제수에 타우린, 이노시톨, 비타민 C, 비타민 B군 (B1, B2, B3,) 및 요오드화칼륨등 주성분과 보조성분들의 상호작용으로서 효능을 나타내는 기능성 음료조성물을 제공한다.
The present invention provides a functional beverage composition exhibiting efficacy as an interaction between main components and auxiliary components such as taurine, inositol, vitamin C, vitamin B group (B1, B2, B3,) and potassium iodide in purified water.
본 발명에서는 기능성 음료 조성물 100ml 중에 비타민 C 100~800mg, 타우린 1000~2000mg, 요오드화칼륨 0.2~0.3mg, 비타민 B군 (B1, B2, B3,) 각 3~50mg 및 이노시톨 50mg~3000mg을 함유하며, 그외에 구연산, 과라나추출분물 자몽종자 추출물을 비롯한 기타의 보조성분을 함유할 수 있다.
In the present invention, 100 ~ 800mg of vitamin C, 1000-2000mg of taurine, 0.2-0.3mg of potassium iodide, 3-50mg of vitamin B group (B1, B2, B3,) and 50mg-3000mg of inositol are contained in 100ml of the functional beverage composition, In addition, citric acid, guarana extract, grapefruit seed extract and other auxiliary ingredients may be contained.
본 발명에서는 상기의 주성분 이외에 사용할 수 있는 보조성분으로서는 감미제, 유기산 또는 그 금속염, 글리세린, 점도조절제, 향료 등이고, 과일주스는 시판 중인 성분을 사용함이 바람직하다. In the present invention, as an auxiliary component that can be used in addition to the above-mentioned main components, sweeteners, organic acids or metal salts thereof, glycerin, viscosity regulators, flavorings, and the like, and fruit juices are preferably commercially available components.
본 발명에서는 사용되는 감미제는 D-솔비톨, 자일리톨과 같은 다가 알콜, 서당, 글루코스, 말토스, 후락토스, 액상 과당, 이성화당과 같은 당류, 스테비오사이드, 꿀에서 선택된 1종 또는 2종 이상 혼합하여 사용될 수 있다. In the present invention, the sweetener used may be a polyhydric alcohol such as D-sorbitol, xylitol, sucrose, glucose, maltose, fructose, liquid fructose, sugars such as isomerized sugars, steviosides, honey or a mixture of two or more selected from Can be used.
본 발명에서 다가알콜로서는 D-솔비톨, 자일리톨 및 글리세린에서 선택된 1종이상의 다가알콜을 사용할 수 있다.As the polyhydric alcohol in the present invention, one or more polyhydric alcohols selected from D-sorbitol, xylitol and glycerin can be used.
본 발명에서 사용되는 유기산은 구연산 또는 그 금속염, 젖산 또는 그 금속염에서 선택된 1종 또는 2종 이상을 혼합하여 사용할 수 있다.The organic acid used in the present invention may be used by mixing one or two or more selected from citric acid or metal salts thereof, lactic acid or metal salts thereof.
본 발명에서 사용되는 향료는 매실향, 허벌향, 스트로베리향 및 통상으로 사용되는 천연 또는 인공향료를 사용할 수 있다.
The fragrance used in the present invention may be used plum, herbal, strawberry and natural or artificial flavors commonly used.
본 발명에서는 기능성 음료 100ml당 감미제 1~10g을 함유할 수 있다.In the present invention may contain 1 ~ 10g of sweetener per 100ml of functional drinks.
본 발명에서는 기능성 음료 100ml당 유기산 또는 유기산염 0.1~1.000mg을 함유할 수 있다. In the present invention may contain 0.1 ~ 1.000mg of organic acid or organic acid per 100ml functional drink.
본 발명에서는 기능성 음료로서 점도를 조절하기 위하여 점도 조절제를 함유할 수 있다. 이때 사용될 수 있는 점도 조절제는 겔란검, 구아검, 알기닌산 나트륨염, CMC 소디움에서 선택된 점도 조절제를 사용한다.In the present invention, a functional beverage may contain a viscosity modifier in order to adjust the viscosity. Viscosity modifiers that can be used at this time use a viscosity modifier selected from gellan gum, guar gum, sodium alginate salt, CMC sodium.
본 발명에서는 기능성 음료 100ml당 과일주스 또는 과일추출물 적량 함유한다.In the present invention, fruit juice or fruit extract is contained in an amount per 100 ml of functional beverage.
본 발명에서는 보존성을 향상시키기 위하여 천연방부제 또는 일반보존제를 첨가할 수도 있다. 이러한 보존제로서는 안식향산나트륨, p-메틸 안식향산, p-에틸안식향산, p-프로필안식향산 또는 이들의 알칼리금속나트륨을 사용할 수 있으며, 그 사용량은 기능성 음료 조성물 100mg당 1mg 내지 100mg을 사용할 수 있다.
In the present invention, a natural preservative or a general preservative may be added to improve the preservation. As such a preservative, sodium benzoate, p-methyl benzoic acid, p-ethyl benzoic acid, p-propyl benzoic acid or sodium alkali metals thereof can be used, and the amount of the preservative may be used in an amount of 1 mg to 100 mg per 100 mg of the functional beverage composition.
본 발명에서 사용되는 향료는 레몬향, 그레이프에센스, 파인애플푸레바, 오렌지에센스, 자몽 후레바, 드링크 후레바 및 통상으로 사용되는 다양한 천연 또는 인공향료를 사용할 수 있다.
The fragrance used in the present invention may be used lemon lemon, grape essence, pineapple purea, orange essence, grapefruit flavor, drink flavor and various natural or artificial flavors commonly used.
본 발명에서 사용되는 과일주스는 오렌지 주스 또는 오렌지추출물, 레몬주스 또는 레몬주스추출물, 자몽 주스, 사과주스 또는 사과추출물, 딸기주스 또는 딸기추출물, 복숭아주스 또는 복숭아추출물, 자두주스 또는 자두추출물, 망고주스 또는 망고 추출물 및 파파야주스 또는 파파야 추출물에서 선택된 과일주스 또는 과일추출물에서 선택된 1종 또는 2종 이상을 혼합하여 사용할 수 있다.
The fruit juice used in the present invention is orange juice or orange extract, lemon juice or lemon juice extract, grapefruit juice, apple juice or apple extract, strawberry juice or strawberry extract, peach juice or peach extract, plum juice or plum extract, mango juice Alternatively, one or two or more selected from mango extract and papaya juice or fruit juice or fruit extract selected from papaya extract may be used.
본 발명에서 유기산의 금속염으로서는 나트륨염, 칼륨염, 마그네슘염에서 선택된 염을 사용할 수 있다.
As the metal salt of the organic acid in the present invention, salts selected from sodium salts, potassium salts and magnesium salts can be used.
본 발명은 타우린, 이노시톨, 비타민 C, 비타민 B군 (비타민 B1, 비타민 B2, 니코틴산아미드, 판토텐산칼슘) 및 요오드화칼륨을 주요성분으로 함유하는 기능성 음료조성물로서 여기에 감미제, 유기산 또는 그 금속염, 다가알콜, 점도조절제, 향료, 보존제 및 과일주스에서 선택된 1종 이상의 성분을 더 함유하는 기능성 음료조성물을 조성하는 것으로 간기능 장해 및 혈중 지질변화 개선작용이 있어 체내 유해물질을 제거하는 해독작용 및 혈중 콜레스테롤 저하, 간기능을 강화시키고 항산화 기능 및 두뇌 발달, 시각능력을 향상까지 확인된 타우린, 우리몸에 꼭 필요한 원소이며 갑상선 호르몬인 티록신과 티록신 유도체를 형성하는 과정에 필수성분인 요오드는 핵분열 생성시 발생하는 암위발 131I 흡수를 억제하는데 요오드를 포함된 요오드화칼륨, 강력한 항산화제로서 피부미백, 피부미용에 큰 도움을 주는 비타민 C와 항피로, 정상적인 발육과 영양분들에 필수 불가결한 미량의 물질의 통칭인 비타민 B군 등이 합리적으로 배합된 것을 특징으로 하는 방사능 관련 해독 기능을 보강한 기능성 음료조성물을 제공하는 것이다.
The present invention is a functional beverage composition containing taurine, inositol, vitamin C, vitamin B group (vitamin B1, vitamin B2, nicotinic acid amide, calcium pantothenate) and potassium iodide as main components, as sweeteners, organic acids or metal salts thereof, and polyalcohols. It is a functional beverage composition which contains at least one ingredient selected from viscosity, flavoring agent, flavoring agent, preservative and fruit juice.It has the effect of improving liver function disorder and blood lipid change and thus detoxifying and removing blood cholesterol. Taurine has been found to enhance liver function, improve antioxidant function and brain development, and visual ability.Iodine, an essential ingredient in the formation of thyroid hormones thyroxine and thyroxine derivatives, is an essential element in our body. Potentially strong 131 I Potassium iodide containing iodine to inhibit absorption Antioxidant-related detoxification, which is reasonably formulated with vitamin C and anti-fatigue as antioxidants, collectively known as vitamin B group, which is a collective name of trace substances indispensable for normal development and nutrients It is to provide a functional beverage composition with enhanced functionality.
다음의 실시예로서 본 발명은 더욱 구체적으로 설명한다.
The present invention is explained in more detail by the following examples.
실시예1
Example 1
원료명 함량Raw Material Name Content
타우린 1000mgTaurine 1000mg
요오드화륨 0.2mg 0.2 mg of iodide
이노시톨 50mg Inositol 50mg
니코틴산아미드 20mg20 mg nicotinic acid
비타민B2인산에스테르나트륨 2mgVitamin B2 Phosphate Sodium 2mg
비타민B1염산염 5mg Vitamin B1 Hydrochloride 5mg
비타민C 500mgVitamin C 500mg
자몽종자추출물 20mgGrapefruit Seed Extract 20mg
백당 10g10g per bag
액상과당 5g5g liquid fructose
구연산 200mg200 mg citric acid
정제염 30mg30 mg of refined salt
솔비톨액 1g1g Sorbitol Liquid
사과과즙7배 농축액 500mgApple Juice 7x Concentrate 500mg
과라나추출분말 10mgGuarana Extract Powder 10mg
로얄젤리 20mgRoyal Jelly 20mg
레몬향(L-22006) 0.008mLLemon Flavor (L-22006) 0.008mL
그레이프에센스(F-723) 0.04mLGrape essence (F-723) 0.04mL
파인애플후레바(P-8054) 0.01mLPineapple Flavor (P-8054) 0.01mL
오렌지에센스 0.1mLOrange Essence 0.1mL
드링크후레바(D-10007) 0.04mLDrinks flavor (D-10007) 0.04mL
수크랄로스 6mgSucralose 6mg
정제수 적량을가하여By adding appropriate amount of purified water
전체 100ml로 함
100 ml total
제조방법Manufacturing method
1) 90 정제수에 요오드화칼륨, 타우린, 이노시톨, 자몽종자추출물, 백당, 액상과당, 구연산, 정제염, 사과과즙 7배 농축액, 솔비톨액, 과라나 추출분말, 로얄젤리, 수크랄로스를 가하여 교반, 용해한다.
1) Add potassium iodide, taurine, inositol, grapefruit seed extract, white sugar, liquid fructose, citric acid, refined salt, apple juice 7-fold concentrate, sorbitol solution, guarana extract powder, royal jelly and sucralose to 90 purified water, and stir.
2) 1)의 액을 40로 냉각시킨 후 비타민C, 염산치아민, 비타민B2인산에스테르나트륨, 니코틴산아미드, 레몬향, 그레이프에센스, 파인애플후레바, 오렌지에센스, 드링크후레바를 가하여 용해 후 표선하고, 5마이므로 필터로 여과한 후 충전하여 밀봉한다.
2) After cooling the solution of 1) to 40, add Vitamin C, Chiamine Hydrochloride, Vitamin B2 Phosphate Sodium, Nicotinamide, Lemon Flavor, Grape Essence, Pineapple Flavor, Orange Essence, Drink Flavor, and dissolve and mark. The filter is then filled with a filter and sealed.
실시예2
Example 2
원료명 함량Raw Material Name Content
타우린 1200mgTaurine 1200mg
요오드화칼륨 0.2mg 0.2 mg potassium iodide
이노시톨 60mg Inositol 60mg
니코틴산아미드 30mgNicotinamide 30mg
비타민B2인산에스테르나트륨 3mgVitamin B2 Phosphate Sodium 3mg
비타민B1염산염 8mg Vitamin B1 Hydrochloride 8mg
비타민C 700mgVitamin C 700mg
자몽종자추출물 20mgGrapefruit Seed Extract 20mg
백당 10g10g per bag
액상과당 5g5g liquid fructose
구연산 200mg200 mg citric acid
정제염 30mg30 mg of refined salt
솔비톨액 1g1g Sorbitol Liquid
사과과즙7배 농축액 500mgApple Juice 7x Concentrate 500mg
과라나추출분말 10mgGuarana Extract Powder 10mg
로얄젤리 20mgRoyal Jelly 20mg
레몬향(L-22006) 0.008mLLemon Flavor (L-22006) 0.008mL
그레이프에센스(F-723) 0.04mLGrape essence (F-723) 0.04mL
파인애플후레바(P-8054) 0.01mLPineapple Flavor (P-8054) 0.01mL
오렌지에센스 0.1mLOrange Essence 0.1mL
드링크후레바(D-10007) 0.04mLDrinks flavor (D-10007) 0.04mL
수크랄로스 6mgSucralose 6mg
정제수 적량을가하여By adding appropriate amount of purified water
전체 100ml로 함
100 ml total
제조방법Manufacturing method
1) 90 정제수에 요오드화칼륨, 타우린, 이노시톨, 자몽종자추출물, 백당, 액상과당, 구연산, 정제염, 사과과즙 7배 농축액, 솔비톨액, 과라나추출분말, 로얄젤리, 수크랄로스를 가하여 교반, 용해한다.
1) Add potassium iodide, taurine, inositol, grapefruit seed extract, white sugar, liquid fructose, citric acid, refined salt, apple juice 7-fold concentrate, sorbitol liquid, guarana extract powder, royal jelly, and sucralose to 90 purified water, and stir.
2) 1)의 액을 40로 냉각시킨 후 비타민C, 염산치아민, 비타민B 2인산에스테르나트륨, 니코틴산아미드, 레몬향, 그레이프에센스, 파인애플후레바, 오렌지에센스, 드링크후레바를 가하여 용해 후 표선하고, 5마이므로 필터로 여과한 후 충전하여 밀봉한다.2) After cooling the solution of 1) to 40, add Vitamin C, Chiamine Hydrochloride, Vitamin B Diphosphate Sodium, Nicotinamide, Lemon Flavor, Grape Essence, Pineapple Flavor, Orange Essence, Drink Flavor and dissolve. Since it is 5 m, it is filtered through a filter and then filled and sealed.
실시예3
Example 3
원료명 함량Raw Material Name Content
타우린 1500mgTaurine 1500mg
요오드화칼륨 0.2mg 0.2 mg potassium iodide
이노시톨 70mg Inositol 70mg
니코틴산아미드 50mgNicotinic Acid 50mg
비타민B2인산에스테르나트륨 5mgVitamin B2 Phosphate Sodium 5mg
비타민B1염산염 10mg Vitamin B1 Hydrochloride 10mg
비타민C 600mgVitamin C 600mg
자몽종자추출물 20mgGrapefruit Seed Extract 20mg
백당 10g10g per bag
액상과당 5g5g liquid fructose
구연산 200mg200 mg citric acid
정제염 30mg30 mg of refined salt
솔비톨액 1g1g Sorbitol Liquid
사과과즙7배 농축액 500mgApple Juice 7x Concentrate 500mg
과라나추출분말 10mgGuarana Extract Powder 10mg
로얄젤리 20mgRoyal Jelly 20mg
레몬향(L-22006) 0.008mLLemon Flavor (L-22006) 0.008mL
그레이프에센스(F-723) 0.04mLGrape essence (F-723) 0.04mL
파인애플후레바(P-8054) 0.01mLPineapple Flavor (P-8054) 0.01mL
오렌지에센스 0.1mLOrange Essence 0.1mL
드링크후레바(D-10007) 0.04mLDrinks flavor (D-10007) 0.04mL
수크랄로스 6mgSucralose 6mg
정제수 적량을가하여By adding appropriate amount of purified water
전체 100ml로 함
100 ml total
제조방법Manufacturing method
1) 90 정제수에 요오드화칼륨, 타우린, 이노시톨, 자몽종자추출물, 백당, 액상과당, 구연산, 정제염, 사과과즙 7배 농축액, 솔비톨액, 과라나추출분말,로얄젤리, 수크랄로스를 가하여 교반, 용해한다.
1) Add potassium iodide, taurine, inositol, grapefruit seed extract, white sugar, liquid fructose, citric acid, refined salt, apple juice 7-fold concentrate, sorbitol liquid, guarana extract powder, royal jelly and sucralose to 90 purified water, and dissolve.
2) 1)의 액을 40로 냉각시킨 후 비타민C, 염산치아민, 비타민B2인산에스테르나트륨, 니코틴산아미드, 레몬향, 그레이프에센스, 파인애플후레바, 오렌지에센스, 드링크후레바를 가하여 용해 후 표선하고, 5마이므로 필터로 여과한 후 충전하여 밀봉한다.2) After cooling the solution of 1) to 40, add Vitamin C, Chiamine Hydrochloride, Vitamin B2 Phosphate Sodium, Nicotinamide, Lemon Flavor, Grape Essence, Pineapple Flavor, Orange Essence, Drink Flavor, and dissolve and mark. The filter is then filled with a filter and sealed.
실시예4
Example 4
원료명 함량Raw Material Name Content
타우린 1700mgTaurine 1700mg
요오드화칼륨 0.2mg 0.2 mg potassium iodide
이노시톨 80mg Inositol 80mg
니코틴산아미드 40mgNicotinamide 40mg
비타민B2인산에스테르나트륨 6mgVitamin B2 Phosphate Sodium 6mg
비타민B1염산염 5mg Vitamin B1 Hydrochloride 5mg
비타민C 800mgVitamin C 800mg
자몽종자추출물 20mgGrapefruit Seed Extract 20mg
백당 10g10g per bag
액상과당 5g5g liquid fructose
구연산 200mg200 mg citric acid
정제염 30mg30 mg of refined salt
솔비톨액 1g1g Sorbitol Liquid
사과과즙7배 농축액 500mgApple Juice 7x Concentrate 500mg
과라나추출분말 10mgGuarana Extract Powder 10mg
로얄젤리 20mgRoyal Jelly 20mg
레몬향(L-22006) 0.008mLLemon Flavor (L-22006) 0.008mL
그레이프에센스(F-723) 0.04mLGrape essence (F-723) 0.04mL
파인애플후레바(P-8054) 0.01mLPineapple Flavor (P-8054) 0.01mL
오렌지에센스 0.1mLOrange Essence 0.1mL
드링크후레바(D-10007) 0.04mLDrinks flavor (D-10007) 0.04mL
수크랄로스 6mgSucralose 6mg
정제수 적량을 가하여By adding appropriate amount of purified water
전체 100ml로 함
100 ml total
제조방법Manufacturing method
1) 90 정제수에 요오드화칼륨, 타우린, 이노시톨, 자몽종자추출물, 백당, 액상과당, 구연산, 정제염, 사과과즙 7배 농축액, 솔비톨액, 과라나추출분말, 로얄젤리, 수크랄로스를 가하여 교반, 용해한다.
1) Add potassium iodide, taurine, inositol, grapefruit seed extract, white sugar, liquid fructose, citric acid, refined salt, apple juice 7-fold concentrate, sorbitol liquid, guarana extract powder, royal jelly, and sucralose to 90 purified water, and stir.
2) 1)의 액을 40로 냉각시킨 후 비타민C, 염산치아민, 비타민B2인산에스테르나트륨, 니코틴산아미드, 레몬향, 그레이프에센스, 파인애플후레바, 오렌지에센스, 드링크후레바를 가하여 용해 후 표선하고, 5마이므로 필터로 여과한 후 충전하여 밀봉한다.2) After cooling the solution of 1) to 40, add Vitamin C, Chiamine Hydrochloride, Vitamin B2 Phosphate Sodium, Nicotinamide, Lemon Flavor, Grape Essence, Pineapple Flavor, Orange Essence, Drink Flavor, and dissolve and mark. The filter is then filled with a filter and sealed.
실시예5Example 5
원료명 함량Raw Material Name Content
타우린 1900mgTaurine 1900 mg
요오드화칼륨 0.3mg 0.3 mg potassium iodide
이노시톨 70mg Inositol 70mg
니코틴산아미드 30mgNicotinamide 30mg
비타민B2인산에스테르나트륨 5mgVitamin B2 Phosphate Sodium 5mg
비타민B1염산염 7mg Vitamin B1 Hydrochloride 7mg
비타민C 700mgVitamin C 700mg
자몽종자추출물 20mgGrapefruit Seed Extract 20mg
백당 10g10g per bag
액상과당 5g5g liquid fructose
구연산 200mg200 mg citric acid
정제염 30mg30 mg of refined salt
솔비톨액 1g1g Sorbitol Liquid
사과과즙7배 농축액 500mgApple Juice 7x Concentrate 500mg
과라나추출분말 10mgGuarana Extract Powder 10mg
로얄젤리 20mgRoyal Jelly 20mg
레몬향(L-22006) 0.008mLLemon Flavor (L-22006) 0.008mL
그레이프에센스(F-723) 0.04mLGrape essence (F-723) 0.04mL
파인애플후레바(P-8054) 0.01mLPineapple Flavor (P-8054) 0.01mL
오렌지에센스 0.1mLOrange Essence 0.1mL
드링크후레바(D-10007) 0.04mLDrinks flavor (D-10007) 0.04mL
수크랄로스 6mgSucralose 6mg
정제수 적량을 가하여By adding appropriate amount of purified water
전체 100ml로 함
100 ml total
제조방법Manufacturing method
1) 90 정제수에 요오드화칼륨, 타우린, 이노시톨, 자몽종자추출물, 백당, 액상과당, 구연산, 정제염, 사과과즙 7배 농축액, 솔비톨액, 과라나추출분말, 로얄젤리, 수크랄로스를 가하여 교반, 용해한다.
1) Add potassium iodide, taurine, inositol, grapefruit seed extract, white sugar, liquid fructose, citric acid, refined salt, apple juice 7-fold concentrate, sorbitol liquid, guarana extract powder, royal jelly, and sucralose to 90 purified water, and stir.
2) 1)의 액을 40로 냉각시킨 후 비타민C, 염산치아민, 비타민B2 인산에스테르나트륨, 니코틴산아미드, 레몬향, 그레이프에센스, 파인애플 후레바, 오렌지에센스, 드링크후레바를 가하여 용해 후 표선하고, 5마이크로 필터로 여과한 후 충전하여 밀봉한다.
2) After cooling the solution of 1) to 40, add vitamin C, hydrochloric acid, vitamin B2 sodium phosphate ester, nicotinic acid amide, lemon flavor, grape essence, pineapple flavor, orange essence, and drink flavor. After filtration through a micro filter, it is filled and sealed.
실시예6Example 6
원료명 함량Raw Material Name Content
타우린 2000mgTaurine 2000mg
요오드화칼륨 0.3mg 0.3 mg potassium iodide
이노시톨 70mg Inositol 70mg
니코틴산아미드 40mgNicotinamide 40mg
비타민B2인산에스테르나트륨 7mgVitamin B2 Phosphate Sodium 7mg
비타민B1염산염 8mg Vitamin B1 Hydrochloride 8mg
비타민C 550mgVitamin C 550mg
자몽종자추출물 20mgGrapefruit Seed Extract 20mg
백당 10g10g per bag
액상과당 5g5g liquid fructose
구연산 200mg200 mg citric acid
정제염 30mg30 mg of refined salt
솔비톨액 1g1g Sorbitol Liquid
사과과즙7배 농축액 500mgApple Juice 7x Concentrate 500mg
과라나추출분말 10mgGuarana Extract Powder 10mg
로얄젤리 20mgRoyal Jelly 20mg
레몬향(L-22006) 0.008mLLemon Flavor (L-22006) 0.008mL
그레이프에센스(F-7 0.04mLGrape essence (F-7 0.04mL
파인애플후레바(P-8054) 0.01mLPineapple Flavor (P-8054) 0.01mL
오렌지에센스 0.1mLOrange Essence 0.1mL
드링크후레바(D-10007) 0.04mLDrinks flavor (D-10007) 0.04mL
수크랄로스 6mgSucralose 6mg
정제수 적량을 가하여By adding appropriate amount of purified water
전체 100ml로 함
100 ml total
제조방법Manufacturing method
1) 90 정제수에 요오드화칼륨, 타우린, 이노시톨, 자몽종자추출물, 백당, 액상과당, 구연산, 정제염, 사과과즙 7배 농축액, 솔비톨액, 과라나추출분말, 로얄젤리, 수크랄로스를 가하여 교반, 용해한다.
1) Add potassium iodide, taurine, inositol, grapefruit seed extract, white sugar, liquid fructose, citric acid, refined salt, apple juice 7-fold concentrate, sorbitol liquid, guarana extract powder, royal jelly, and sucralose to 90 purified water, and stir.
2) 1)의 액을 40로 냉각시킨 후 비타민C, 염산치아민, 비타민B2 인산에스테르나트륨, 니코틴산아미드, 레몬향, 그레이프에센스, 파인애플후레바, 오렌지에센스, 드링크후레바를 가하여 용해 후 표선하고, 5마이크로 필터로 여과한 후 충전하여 밀봉한다.2) After cooling the solution of 1) to 40, add Vitamin C, Chiamine Hydrochloride, Vitamin B2 Sodium Phosphate, Nicotinamide, Lemon Flavor, Grape Essence, Pineapple Flavor, Orange Essence, Drink Flavor, and dissolve and mark. After filtration through a micro filter, it is filled and sealed.
Claims (8)
Purified water contains taurine, inositol, vitamin C, vitamin B group and potassium iodide as main ingredients, and contains at least one component selected from sweeteners, organic acids or metal salts thereof, polyhydric alcohols, viscosity modifiers, flavors, preservatives and fruit juices. Functional beverage composition.
According to claim 1, containing 100 ~ 2000mg of taurine, 3 ~ 50mg of vitamin C complex, 100 ~ 800mg of vitamin C, inositol, 30 ~ 3000mg, potassium iodide 0.2 ~ 0.3mg per 100ml of functional beverage composition, and as a secondary sweetener A functional beverage composition further comprising at least one auxiliary ingredient selected from organic acids or metal salts thereof, polyhydric alcohols, viscosity modifiers, flavoring agents, preservatives and fruit juices.
The functional beverage composition according to claim 1, wherein the sweetener comprises one or two or more sugars selected from sucrose, glucose, maltose, fructose, isomerized sugar, stevioside and honey.
The functional beverage composition according to claim 1, wherein the organic acid or metal salt thereof is one or two or more organic acids selected from citric acid or metal salts thereof, lactic acid or metal salts thereof, and metal salts.
The fruit juice or fruit extract of claim 1 is an apple juice concentrate, orange juice or orange extract, lemon juice or lemon extract, grapefruit juice or grapefruit seed extract, apple juice or apple extract, strawberry juice or strawberry extract, peach juice or peach Functional beverage composition of one or more selected from fruit juice or fruit extract selected from extracts, plum juice or plum extract, mango juice or mango extract and papaya juice or papaya extract.
The functional beverage composition of claim 1, wherein the viscosity modifier is a viscosity modifier selected from gellan gum, guar gum, sodium alginate salt, CMC sodium.
The functional beverage composition according to claim 1, wherein the preservative is a preservative selected from sodium benzoate, p-methyl benzoic acid, p-ethyl benzoic acid, p-propyl benzoic acid or alkali metal sodium thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110029163A KR20120110955A (en) | 2011-03-31 | 2011-03-31 | A functional beverage composition comprising taurine, inositol, vitamin c, vitamin b complex, potassium iodide as main ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110029163A KR20120110955A (en) | 2011-03-31 | 2011-03-31 | A functional beverage composition comprising taurine, inositol, vitamin c, vitamin b complex, potassium iodide as main ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20120110955A true KR20120110955A (en) | 2012-10-10 |
Family
ID=47281710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110029163A KR20120110955A (en) | 2011-03-31 | 2011-03-31 | A functional beverage composition comprising taurine, inositol, vitamin c, vitamin b complex, potassium iodide as main ingredients |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20120110955A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104397711A (en) * | 2014-12-19 | 2015-03-11 | 贵州威门药业股份有限公司 | Oral liquid for enhancing immunity and relieving fatigue |
CN109452651A (en) * | 2018-08-14 | 2019-03-12 | 北京恒创知远生物技术有限公司 | Endurance composition |
KR102699382B1 (en) * | 2024-01-10 | 2024-08-27 | 주식회사 마일포스트 | Hemp seed beverage composition and method for manufacturing the same |
-
2011
- 2011-03-31 KR KR1020110029163A patent/KR20120110955A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104397711A (en) * | 2014-12-19 | 2015-03-11 | 贵州威门药业股份有限公司 | Oral liquid for enhancing immunity and relieving fatigue |
CN109452651A (en) * | 2018-08-14 | 2019-03-12 | 北京恒创知远生物技术有限公司 | Endurance composition |
KR102699382B1 (en) * | 2024-01-10 | 2024-08-27 | 주식회사 마일포스트 | Hemp seed beverage composition and method for manufacturing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0514451B1 (en) | Dietary supplements comprising vitamins and minerals | |
US6451341B1 (en) | Time release formulation of vitamins, minerals and other beneficial supplements | |
ES2201467T3 (en) | NUTRITIVE COMPOSITION FOR THE ENERGETIC IMPROVEMENT OF THE CELL. | |
ES2286238T3 (en) | COMPOSITION FOR REHYDRATION. | |
US20030143311A1 (en) | Recovery drink formula and method | |
JP2007291135A (en) | Pharmaceutical compositions for alleviating discomfort | |
CA2747753C (en) | Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health | |
EA025137B1 (en) | Dialysis solution comprising one or more creatine compounds and method for preparing the same | |
KR20170104575A (en) | A carboxylic acid mixture for treating patients with kidney failure | |
US20030104107A1 (en) | Energy drink formula and method | |
KR20120010680A (en) | A functional beverage composition comprising taurine, L-carnitine, vitamin C, vitamine B complex, and color selected from caramel color and sepia color | |
ES2386635T3 (en) | Multivitamin syrup for children or young adults | |
RU2472354C1 (en) | Biologically active food additive "selenium-iodine-elastin" | |
RU2665635C2 (en) | Multivitamin/mineral composition for controlling environmental stress effects; improving immunity and increasing activity, aiming at vitamin and mineral insufficiency with no negative side effects of mega-dosage food additive | |
JP2007197363A (en) | Nutritional supplement | |
KR100613618B1 (en) | Method for maintaining oxidative metabolism attendant upon exercise and food for sport | |
KR20120110955A (en) | A functional beverage composition comprising taurine, inositol, vitamin c, vitamin b complex, potassium iodide as main ingredients | |
US20130064924A1 (en) | Nutritional supplement for use under physiologically stressful conditions | |
Singh et al. | 19 Vitamins and Minerals: Roles and Plant Sources | |
Vinishdharma et al. | Vitamin C as a therapeutic healing agent. | |
EP3503745B1 (en) | Dietary macro/micronutritional supplement for patients undergoing kidney dialysis | |
KR20120119686A (en) | A functional beverage composition comprising l-arginine, vitamin c, vitamin b complex, vitamin a, vitamin e and potassium iodide as main ingredients | |
EP3244877A1 (en) | Oral delivery product | |
EA017041B1 (en) | Multivitamin composition | |
WO2013093863A1 (en) | Beverage compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |